Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IRAK3 |
| Upstream (Parents) |
|---|
| (<<) CSF2RB → IRAK3 |
| (<<) CD69 → IRAK3 |
| (<<) PRKAR2B → IRAK3 |
| (<<) FAM49A → IRAK3 |
| (<<) LDOC1 → IRAK3 |
| (<<) DSE → IRAK3 |
| (<<) LCP2 → IRAK3 |
| (<<) WIPF1 → IRAK3 |
| Downstream (Children) |
|---|
| IRAK3 → CARD14 (>>) |
| IRAK3 → WDFY3 (>>) |
| IRAK3 → SUSD5 (>>) |
| IRAK3 → KLRC2///KLRC1 (>>) |
| IRAK3 → FCAR (>>) |
| IRAK3 → BEND5 (>>) |
| IRAK3 → PDZD2 (>>) |
| IRAK3 → TMEFF1 (>>) |
| IRAK3 → CD69 (>>) |
| IRAK3 → IL3 (>>) |
| IRAK3 → PTX3 (>>) |
| IRAK3 → PRKAR2B (>>) |
| IRAK3 → FAM49A (>>) |
| IRAK3 → LPAR4 (>>) |
| IRAK3 → WNT5A (>>) |
| IRAK3 → GPR176 (>>) |
| IRAK3 → C16orf72 (>>) |
| IRAK3 → IL7 (>>) |
| IRAK3 → OR7C2 (>>) |
